Belite Bio (BLTE)
(Delayed Data from NSDQ)
$48.68 USD
+0.22 (0.45%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $47.65 -1.03 (-2.12%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.30 | -10.00% |
Earnings Summary
For their last quarter, Belite Bio (BLTE) reported earnings of -$0.31 per share, missing the Zacks Consensus Estimate of -$0.28 per share. This reflects a negative earnings surprise of 10.71%. Look out for BLTE's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 25%.
Earnings History
Price & Consensus
Zacks News for BLTE
Belite Bio (BLTE) Stock Surges 72% in a Month: Here's Why
BLTE: What are Zacks experts saying now?
Zacks Private Portfolio Services